作者: Joana F. Fangueiro , Patrícia Severino , Selma B. Souto , Eliana B. Souto
DOI: 10.1007/978-3-642-29265-1_15
关键词:
摘要: Immunization and treatment of infectious diseases is been extensively exploited to develop better safe vaccines. The efforts have made improve the effectiveness vaccines for this reason nanomedicine emerges as ultimate alternative. Most common diseases, such hepatite B virus (HBV), human immunodeficiency virus/ acquired immune deficiency syndrome (HIV/AIDS) malaria, papillomavirus (HPV) tuberculosis (TB), aggressive prolonged treatments, purpose development novel therapeutic systems a priority aiming at reducing cytotoxicity drug resistance. Examples these are solid lipid nanoparticles (SLN), polymeric, inorganic, metallic, magnetic, viral-based dendrimers that received more attention their proven efficiency in providing immunization, targeting triggering antibody response cellular level. This review focuses on towards approaches also patented marketed formulations nanocarrier-based vaccine formulations.